Opportunity
Federal Register #2026-17589
DEA Revocation and Suspension of Controlled Substance Registrations for Dr. Leila Kump and Atlantic Treatment Center
Buyer
Drug Enforcement Administration
Posted
August 28, 2026
Identifier
2026-17589
This notice details enforcement actions by the Drug Enforcement Administration (DEA) regarding controlled substance registrations: - Government Buyer: - Drug Enforcement Administration (DEA), Department of Justice - Actions Taken: - Revocation of Dr. Leila Kump, M.D.'s DEA registration (No. FK6611013) due to: - Lack of valid state medical license - Unsafe prescribing practices resulting in two patient deaths from opioid and benzodiazepine intoxication - Immediate suspension and proposed revocation of Atlantic Treatment Center, LLC's DEA registration (No. RA0645400) due to: - Revocation of state license - Withdrawal of federal certification for substance use disorder treatment - Notable Requirements: - Emphasis on compliance with state authority and public safety in dispensing controlled substances - No products, OEMs, or commercial vendors are involved; this is a regulatory enforcement action, not a procurement opportunity.
Description
This notice announces the decision and order regarding Dr. Leila Kump by the Drug Enforcement Administration. It details the agency's actions related to the revocation of Dr. Kump's registration to dispense controlled substances due to non-compliance with the Controlled Substances Act. The document includes legal references, the rationale for the decision, and links to full text and supporting documents. The order is effective September 28, 2026.